UBS/CALL/MODERNA/160.001/0.1/21.03.25 Share Price

Warrant

TMRN5U

CH1330871984

Market Closed - Swiss Exchange 08:50:00 24/05/2024 pm IST
3.44 CHF +7.17% Intraday chart for UBS/CALL/MODERNA/160.001/0.1/21.03.25
Current month+286.52%
1 month+352.63%
Date Price Change
24/24/24 3.44 +7.17%
23/24/23 3.21 +11.07%
22/24/22 2.89 +57.92%
21/24/21 1.83 +26.21%
17/24/17 1.45 +2.11%

Delayed Quote Swiss Exchange

Last update May 24, 2024 at 08:50 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MODERNA, INC.
Issuer UBS
TMRN5U
ISINCH1330871984
Date issued 18/03/2024
Strike 160 $
Maturity 21/03/2025 (301 Days)
Parity 10 : 1
Emission price 0.76 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 3.44 CHF
Lowest since issue 0.66 CHF
Spread 0.05 CHF
Spread %1.43%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
164 USD
Average target price
138.5 USD
Spread / Average Target
-15.55%
Consensus
  1. Stock Market
  2. Warrants
  3. TMRN5U Warrant